Jérôme Fayette
Université Claude Bernard Lyon 1(FR)Université de Lyon(FR)Centre Léon Bérard(FR)Centre de Recherche en Cancérologie de Lyon(FR)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Diagnosis and Treatment
Most-Cited Works
- → Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer(2015)9,390 cited
- → Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck(2016)4,966 cited
- → Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)(2017)867 cited
- → Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression(2018)786 cited
- → Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma(2017)598 cited
- → Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial